{"id":"W2023037752","doi":"10.1016/s1094-5539(02)00175-x","title":"Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294","year":2003,"lang":"en","type":"review","venue":"Pulmonary Pharmacology & Therapeutics","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Rolipram; Phosphodiesterase 3; Chemistry; Pharmacology; In vitro; In vivo; Phosphodiesterase; Cyclic nucleotide phosphodiesterase; Lipopolysaccharide; Cyclic nucleotide; Endocrinology; Internal medicine; Medicine; Biochemistry; Biology; Nucleotide; Enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002590774,0.0008206484,0.00143365,0.0002272597,0.0001570974,0.00001946918,0.000526352,0.000964814,0.0006793738],"category_scores_gemma":[0.00000517118,0.0007531066,0.0006272214,0.0004407964,0.0003292073,0.00001331191,0.0002283881,0.0005768173,0.0001104865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009948576,"about_ca_system_score_gemma":0.0007364871,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009778288,"about_ca_topic_score_gemma":0.000002568197,"domain_scores_codex":[0.9966665,0.0005904146,0.00104232,0.0008609191,0.0002176621,0.0006221829],"domain_scores_gemma":[0.9981785,0.00008291601,0.0007932215,0.0005002208,0.0001818652,0.0002632524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006782396,0.0007917717,0.00004715497,0.002295301,0.002358593,0.00007708043,0.00007402711,0.00003714269,0.09307843,0.00001019548,0.04078633,0.8597657],"study_design_scores_gemma":[0.0008439163,0.0004095123,0.000006210622,0.000266647,0.003588366,0.0002573531,0.00001633688,0.00001526898,0.01961565,0.00002116653,0.9743223,0.0006372231],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00239103,0.9887198,0.00004755623,0.0001131933,0.006869736,0.001067434,0.00006880454,0.00005167528,0.0006707681],"genre_scores_gemma":[0.0004719342,0.9891152,0.0001942864,0.003172,0.001370962,0.00006927927,0.0006878358,0.0001759556,0.004742482],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.933536,"threshold_uncertainty_score":0.999492,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05413083984290545,"score_gpt":0.3563719458341764,"score_spread":0.302241105991271,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}